Anthem Delays Mail-Order Rx Rule In Face Of Bias Suit

Law360, New York (February 19, 2013, 4:52 PM EST) -- In response to a proposed class action alleging discrimination and privacy violations, California health insurer Anthem Blue Cross has backed away from a requirement that patients with certain chronic diseases obtain drugs through a mail-order pharmacy, a consumer rights group said Tuesday.

Consumer Watchdog, which filed an anti-discrimination lawsuit last month on behalf of an unidentified HIV-positive man, released a letter Anthem sent Friday to policyholders announcing it won’t transition March 1 to a mail-order program for certain specialty medicines.

In the correspondence, Anthem suggested customers...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.